0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Observation  | 
Cutaneous Embolization of Doxorubicin Drug-Eluting Beads
Elizabeth Grieshaber, MD; Thomas Nicotri, MD; Rachel Reina, MD; et al.
JAMA Internal Medicine
Original Investigation  | 
Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer:  Results From the Randomized Clinical Trials of Alendronate and Zoledronic Acid
Trisha F. Hue, PhD, MPH; Steven R. Cummings, MD; Jane A. Cauley, DrPH; et al.
JAMA Internal Medicine
Research Letter  | 
Breast Cancer Risk and Use of Calcium Channel Blockers Using Swedish Population Registries
Gudrun Jonasdottir Bergman, PhD; Staffan Khan; Bengt Danielsson, MD, PhD; et al.
JAMA Internal Medicine
Viewpoint  | 
Lessons From the Swiss Medical Board Recommendation Against Mammography Screening Programs
Arnaud Chiolero, MD, PhD; Nicolas Rodondi, MD, MAS